Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Martin Zamora

Concepts (287)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Transplantation
32
2023
326
5.070
 Why?
Cytomegalovirus Infections
7
2012
203
1.590
 Why?
Antiviral Agents
12
2023
774
1.320
 Why?
Respiratory Syncytial Virus Infections
4
2023
139
1.190
 Why?
Lung Diseases
7
2017
787
1.010
 Why?
Bronchiolitis Obliterans
7
2015
59
0.740
 Why?
Ganciclovir
5
2012
51
0.720
 Why?
Respiratory Syncytial Virus, Human
2
2023
81
0.710
 Why?
Postoperative Complications
9
2015
2962
0.640
 Why?
Heart Transplantation
7
2019
679
0.590
 Why?
alpha 1-Antitrypsin Deficiency
2
2018
61
0.550
 Why?
Graft Rejection
10
2019
504
0.550
 Why?
Pneumonia, Viral
1
2023
387
0.520
 Why?
Pulmonary Medicine
1
2017
78
0.490
 Why?
Graft Survival
6
2019
508
0.480
 Why?
Lung
11
2017
4119
0.460
 Why?
Regeneration
1
2017
198
0.450
 Why?
Sirolimus
3
2018
282
0.440
 Why?
Diltiazem
1
2014
17
0.410
 Why?
Bronchial Arteries
2
2010
12
0.400
 Why?
RNA, Small Interfering
2
2015
630
0.360
 Why?
Transplant Recipients
1
2014
168
0.360
 Why?
Transplantation, Homologous
11
2019
415
0.350
 Why?
Organ Transplantation
3
2018
235
0.350
 Why?
Pulmonary Circulation
2
2010
431
0.340
 Why?
Polymorphism, Genetic
1
2014
611
0.340
 Why?
Virus Diseases
2
2011
219
0.320
 Why?
Patient Selection
6
2015
720
0.320
 Why?
Herpesviridae Infections
1
2011
147
0.310
 Why?
Histocompatibility Antigens Class I
1
2012
207
0.310
 Why?
Histocompatibility Antigens Class II
1
2012
365
0.310
 Why?
Epstein-Barr Virus Infections
1
2011
102
0.310
 Why?
RNA Interference
2
2013
470
0.300
 Why?
Pulmonary Emphysema
4
2015
276
0.290
 Why?
Respiratory Tract Infections
2
2011
399
0.280
 Why?
Societies, Medical
4
2018
901
0.280
 Why?
Treatment Outcome
10
2023
11744
0.260
 Why?
Cytomegalovirus
2
2004
169
0.240
 Why?
Gene Expression Regulation
3
2014
2591
0.230
 Why?
Immunosuppressive Agents
5
2019
824
0.230
 Why?
Pulmonary Disease, Chronic Obstructive
5
2015
926
0.220
 Why?
Humans
42
2023
145625
0.220
 Why?
Autoantibodies
2
2013
1498
0.220
 Why?
Vasculitis
1
2005
69
0.220
 Why?
Capillaries
1
2005
123
0.210
 Why?
Drug Resistance, Viral
3
2011
126
0.210
 Why?
Waiting Lists
3
2015
242
0.200
 Why?
Immunoglobulins, Intravenous
1
2004
134
0.200
 Why?
Lymphocyte Function-Associated Antigen-1
2
2018
26
0.200
 Why?
Reperfusion Injury
3
2017
300
0.190
 Why?
Heart-Lung Transplantation
2
2014
12
0.190
 Why?
Indazoles
1
2023
86
0.180
 Why?
Pneumonectomy
2
2018
167
0.180
 Why?
Risk Factors
7
2013
10840
0.180
 Why?
Evidence-Based Medicine
1
2005
727
0.170
 Why?
CD11b Antigen
1
2019
60
0.150
 Why?
Proto-Oncogene Proteins c-kit
1
2019
73
0.150
 Why?
Sulfonamides
1
2023
592
0.140
 Why?
Stem Cell Transplantation
1
2019
189
0.140
 Why?
Transplantation Tolerance
1
2018
40
0.140
 Why?
Primary Graft Dysfunction
2
2017
32
0.130
 Why?
Middle Aged
15
2015
36359
0.130
 Why?
Bronchoalveolar Lavage Fluid
4
2020
641
0.120
 Why?
Endothelial Cells
2
2013
876
0.120
 Why?
Transplantation, Heterotopic
2
2014
16
0.120
 Why?
Respiratory Function Tests
2
2010
543
0.120
 Why?
DNA, Mitochondrial
1
2017
212
0.120
 Why?
Syndrome
3
2015
377
0.120
 Why?
Immune Tolerance
1
2018
384
0.120
 Why?
CD4-Positive T-Lymphocytes
2
2014
1148
0.110
 Why?
Congresses as Topic
1
2017
226
0.110
 Why?
Frailty
1
2018
206
0.110
 Why?
International Cooperation
1
2016
192
0.110
 Why?
Adult
10
2023
40821
0.110
 Why?
Interleukin-18
2
2013
234
0.110
 Why?
Fas Ligand Protein
1
2014
61
0.110
 Why?
Tissue Donors
2
2016
398
0.110
 Why?
Male
18
2015
73014
0.110
 Why?
Cytochrome P-450 CYP2C8
1
2014
14
0.100
 Why?
Asphyxia
1
2014
24
0.100
 Why?
Follow-Up Studies
3
2014
5397
0.100
 Why?
Receptors, Steroid
1
2014
41
0.100
 Why?
Tobacco Smoke Pollution
2
2013
227
0.100
 Why?
Aryl Hydrocarbon Hydroxylases
1
2014
45
0.100
 Why?
Female
18
2019
79080
0.100
 Why?
Tissue and Organ Procurement
2
2015
298
0.100
 Why?
Everolimus
1
2014
112
0.100
 Why?
Anastomosis, Surgical
2
2013
161
0.100
 Why?
Health Resources
1
2015
130
0.100
 Why?
Tissue Distribution
1
2014
334
0.100
 Why?
Cytochrome P-450 CYP3A
1
2014
93
0.100
 Why?
CD146 Antigen
1
2013
38
0.100
 Why?
Ventilator-Induced Lung Injury
1
2014
62
0.100
 Why?
Demography
1
2014
274
0.100
 Why?
Perfusion
1
2014
244
0.090
 Why?
Calcineurin Inhibitors
2
2019
67
0.090
 Why?
Immunocompromised Host
2
2011
201
0.090
 Why?
Extracorporeal Membrane Oxygenation
2
2015
369
0.090
 Why?
Animals
13
2019
38030
0.090
 Why?
Practice Guidelines as Topic
2
2018
1581
0.090
 Why?
Vasodilator Agents
1
2014
326
0.090
 Why?
CD8-Positive T-Lymphocytes
1
2018
929
0.090
 Why?
Mice, Inbred BALB C
4
2019
1244
0.090
 Why?
Liver Transplantation
1
2018
699
0.090
 Why?
Metabolic Clearance Rate
1
2012
115
0.090
 Why?
Predictive Value of Tests
3
2013
2097
0.090
 Why?
Injections, Intravenous
1
2012
197
0.090
 Why?
Seroepidemiologic Studies
1
2012
169
0.080
 Why?
Cytokines
2
2010
2079
0.080
 Why?
Polymerase Chain Reaction
2
2004
1030
0.080
 Why?
Viral Vaccines
1
2011
107
0.080
 Why?
Neprilysin
1
2010
47
0.080
 Why?
Airway Remodeling
1
2010
63
0.080
 Why?
Cell Communication
1
2012
327
0.080
 Why?
Double-Blind Method
2
2015
2064
0.080
 Why?
Gene Expression
1
2014
1461
0.080
 Why?
CD4 Antigens
1
2010
135
0.070
 Why?
Adoptive Transfer
1
2010
197
0.070
 Why?
Cross-Over Studies
1
2012
612
0.070
 Why?
Preoperative Care
1
2012
375
0.070
 Why?
Administration, Inhalation
1
2010
567
0.070
 Why?
T-Lymphocytes, Cytotoxic
1
2010
180
0.070
 Why?
Genotype
1
2014
1866
0.070
 Why?
Respiration, Artificial
1
2014
711
0.070
 Why?
Cost of Illness
1
2011
322
0.070
 Why?
Pulmonary Artery
2
2012
1116
0.070
 Why?
Length of Stay
1
2015
1342
0.070
 Why?
Blood Specimen Collection
1
2008
37
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
973
0.070
 Why?
Bacteriological Techniques
1
2008
66
0.070
 Why?
Regional Blood Flow
1
2010
507
0.070
 Why?
Pulmonary Fibrosis
2
2013
395
0.070
 Why?
C-Reactive Protein
1
2010
427
0.070
 Why?
Macrophages, Alveolar
2
2013
377
0.070
 Why?
Cyclosporine
2
2019
256
0.070
 Why?
Biomarkers
3
2014
4329
0.070
 Why?
Referral and Consultation
1
2014
878
0.070
 Why?
Recurrence
1
2011
1125
0.060
 Why?
Body Temperature
1
2008
227
0.060
 Why?
Dose-Response Relationship, Drug
1
2012
2018
0.060
 Why?
Macrophages
2
2013
1530
0.060
 Why?
Fever
1
2008
320
0.060
 Why?
Trachea
2
2007
253
0.060
 Why?
Mice
9
2019
18266
0.060
 Why?
Time Factors
5
2015
7079
0.060
 Why?
Nurse Practitioners
1
2008
141
0.060
 Why?
Bacteremia
1
2008
218
0.060
 Why?
Terminology as Topic
1
2007
253
0.060
 Why?
Cryptogenic Organizing Pneumonia
1
2005
20
0.060
 Why?
Tissue Transplantation
1
2005
10
0.060
 Why?
Mice, Inbred C57BL
4
2019
6021
0.060
 Why?
CD40 Ligand
1
2005
31
0.060
 Why?
Prognosis
1
2014
4331
0.050
 Why?
Practice Patterns, Physicians'
1
2014
1370
0.050
 Why?
Survival
1
2004
38
0.050
 Why?
Antibodies, Monoclonal
2
2018
1511
0.050
 Why?
Mice, Inbred C3H
2
2018
252
0.050
 Why?
Rats
4
2013
5574
0.050
 Why?
Immunoglobulins
1
2004
162
0.050
 Why?
Drug Resistance
1
2004
145
0.050
 Why?
Aged
7
2014
26251
0.050
 Why?
T-Lymphocytes
1
2012
2007
0.050
 Why?
Drug Administration Schedule
1
2005
782
0.050
 Why?
Quality Assurance, Health Care
1
2005
339
0.050
 Why?
Torsion Abnormality
1
2003
20
0.050
 Why?
Rats, Sprague-Dawley
3
2013
2533
0.050
 Why?
Capillary Permeability
2
2013
132
0.050
 Why?
Registries
1
2012
2382
0.050
 Why?
Fibrosis
1
2005
568
0.050
 Why?
Cross-Sectional Studies
1
2014
5875
0.050
 Why?
Hypoxia
1
2010
1209
0.040
 Why?
Respiratory Mucosa
1
2005
323
0.040
 Why?
Incidence
1
2009
2910
0.040
 Why?
Prevalence
1
2009
2852
0.040
 Why?
Mice, Transgenic
2
2018
2131
0.040
 Why?
Endothelium, Vascular
1
2007
952
0.040
 Why?
Genomics
1
2006
851
0.040
 Why?
Transplantation Immunology
2
2013
28
0.040
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2013
86
0.040
 Why?
Neutrophils
1
2006
1132
0.040
 Why?
Polyphosphates
1
2020
46
0.040
 Why?
Cell Line
3
2013
2809
0.040
 Why?
Ribavirin
1
2020
81
0.040
 Why?
Early Diagnosis
2
2013
249
0.040
 Why?
Young Adult
3
2014
14240
0.040
 Why?
Abatacept
1
2019
56
0.040
 Why?
Mice, Knockout
3
2013
3121
0.040
 Why?
Case-Control Studies
3
2013
3633
0.040
 Why?
Prospective Studies
1
2012
8087
0.040
 Why?
Mice, Inbred Strains
2
2013
384
0.040
 Why?
Allografts
1
2019
148
0.040
 Why?
Adolescent
4
2014
22451
0.040
 Why?
CD28 Antigens
1
2018
57
0.030
 Why?
Myeloid Cells
1
2019
149
0.030
 Why?
Health Care Rationing
1
2018
53
0.030
 Why?
Immunohistochemistry
2
2013
1709
0.030
 Why?
Gene Expression Profiling
1
2004
1790
0.030
 Why?
Sensitivity and Specificity
3
2008
1992
0.030
 Why?
Retrospective Studies
3
2015
17291
0.030
 Why?
Cardiomyopathies
1
2019
339
0.030
 Why?
Isoantibodies
1
2016
57
0.030
 Why?
Acute Disease
2
2010
1033
0.030
 Why?
Stem Cells
1
2019
612
0.030
 Why?
Genes, RAG-1
1
2014
11
0.030
 Why?
DNA Repair
1
2017
254
0.030
 Why?
Cell Movement
2
2012
950
0.030
 Why?
Reactive Oxygen Species
1
2017
610
0.030
 Why?
DNA Damage
1
2017
437
0.030
 Why?
Lymphocyte Activation
1
2018
1136
0.030
 Why?
Tidal Volume
1
2014
108
0.020
 Why?
Chemokine CCL5
1
2013
40
0.020
 Why?
Positive-Pressure Respiration
1
2014
115
0.020
 Why?
Gene Deletion
1
2014
384
0.020
 Why?
Pulmonary Edema
1
2013
104
0.020
 Why?
Aorta, Abdominal
1
2013
51
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2013
74
0.020
 Why?
Patient Admission
1
2015
216
0.020
 Why?
Neck
1
2013
107
0.020
 Why?
Inhalation Exposure
1
2013
103
0.020
 Why?
Rats, Nude
1
2012
25
0.020
 Why?
Immunity, Innate
1
2018
843
0.020
 Why?
Fluoresceins
1
2012
48
0.020
 Why?
Abdomen
1
2013
140
0.020
 Why?
History, 21st Century
1
2013
224
0.020
 Why?
Tobacco Products
1
2013
90
0.020
 Why?
Cardiomegaly
1
2013
175
0.020
 Why?
History, 20th Century
1
2013
330
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2013
372
0.020
 Why?
Cell Death
1
2013
379
0.020
 Why?
Familial Primary Pulmonary Hypertension
1
2012
194
0.020
 Why?
Child
1
2011
22638
0.020
 Why?
Transfection
1
2013
914
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2013
543
0.020
 Why?
Survival Rate
1
2015
2078
0.020
 Why?
Aorta, Thoracic
1
2013
284
0.020
 Why?
Fluorescent Dyes
1
2012
340
0.020
 Why?
Myocytes, Cardiac
1
2014
542
0.020
 Why?
H-2 Antigens
1
2010
111
0.020
 Why?
Myocardium
1
2014
948
0.020
 Why?
Oximetry
1
2010
124
0.020
 Why?
United States
2
2018
16041
0.020
 Why?
Bronchoscopy
1
2010
227
0.020
 Why?
False Positive Reactions
1
2008
124
0.020
 Why?
Patient Discharge
1
2015
991
0.020
 Why?
International Agencies
1
2007
30
0.020
 Why?
Blotting, Western
1
2010
1176
0.020
 Why?
Systemic Inflammatory Response Syndrome
1
2008
96
0.020
 Why?
Receptors, Interleukin-8B
1
2007
29
0.020
 Why?
Pulmonary Alveoli
1
2010
385
0.020
 Why?
Decompression, Surgical
1
2008
113
0.020
 Why?
Weight Loss
1
2013
857
0.020
 Why?
Suicide
1
2014
638
0.020
 Why?
Microcirculation
1
2007
142
0.020
 Why?
Biopsy, Needle
1
2007
182
0.020
 Why?
Cell Survival
1
2010
1102
0.020
 Why?
Evidence-Based Practice
1
2008
230
0.010
 Why?
Chemotaxis, Leukocyte
1
2006
115
0.010
 Why?
Cells, Cultured
1
2013
4112
0.010
 Why?
Transplantation Chimera
1
2005
57
0.010
 Why?
Reoperation
1
2008
633
0.010
 Why?
Eosinophilia
1
2007
224
0.010
 Why?
Oxygen
1
2010
996
0.010
 Why?
Models, Biological
1
2012
1758
0.010
 Why?
Cell Proliferation
1
2012
2497
0.010
 Why?
Ischemia
1
2007
421
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
751
0.010
 Why?
Inpatients
1
2008
538
0.010
 Why?
Biopsy
1
2007
1073
0.010
 Why?
Respiratory System
1
2005
150
0.010
 Why?
Diagnosis, Differential
1
2007
1500
0.010
 Why?
Kinetics
1
2006
1553
0.010
 Why?
Respirovirus
1
2002
6
0.010
 Why?
Virus Cultivation
1
2002
31
0.010
 Why?
Disease Models, Animal
1
2013
4565
0.010
 Why?
Influenza B virus
1
2002
47
0.010
 Why?
Immunoenzyme Techniques
1
2002
196
0.010
 Why?
Pneumonia
1
2007
633
0.010
 Why?
Influenza A virus
1
2002
120
0.010
 Why?
Surveys and Questionnaires
1
2014
6050
0.010
 Why?
Chronic Disease
1
2007
1824
0.010
 Why?
Reproducibility of Results
1
2008
3396
0.010
 Why?
Hypertension, Pulmonary
1
2012
1957
0.010
 Why?
Immunotherapy
1
2005
669
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2766
0.010
 Why?
Transcription, Genetic
1
2004
1429
0.010
 Why?
RNA, Messenger
1
2004
2783
0.010
 Why?
Inflammation
1
2005
2915
0.010
 Why?
Zamora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (287) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)